Beth DelGiacco

Prior to joining argenx, Beth was a Vice President at Stern Investor Relations, an investor relations firm offering biotechnology companies strategic and client-specific advisory services. She has worked in managing institutional investor relationships for over 15 years, previously on the Healthcare team at Guidepoint Global and the Neurology team at Global Data. She holds a Master’s degree in Public Health from Columbia University and a Bachelor’s degree in Chemistry and Spanish from the University of Rochester. She also completed a post-baccalaureate fellowship at the National Institutes of Health.